CareMax Net Worth
CareMax Net Worth Breakdown | CMAX |
CareMax Net Worth Analysis
CareMax's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CareMax's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CareMax's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CareMax's net worth analysis. One common approach is to calculate CareMax's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CareMax's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CareMax's net worth. This approach calculates the present value of CareMax's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CareMax's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CareMax's net worth. This involves comparing CareMax's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CareMax's net worth relative to its peers.
Enterprise Value |
|
To determine if CareMax is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CareMax's net worth research are outlined below:
CareMax generated a negative expected return over the last 90 days | |
CareMax has high historical volatility and very poor performance | |
CareMax has some characteristics of a very speculative penny stock | |
CareMax has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 751.1 M. Net Loss for the year was (683.35 M) with profit before overhead, payroll, taxes, and interest of 80.3 M. | |
CareMax currently holds about 68.13 M in cash with (46.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
CareMax has a frail financial position based on the latest SEC disclosures | |
Roughly 24.0% of the company shares are held by company insiders | |
Latest headline from benzinga.com: Gold Down Over 3 Rigetti Computing Shares Spike Higher |
CareMax Quarterly Good Will |
|
CareMax uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CareMax. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CareMax's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of March 2024 Upcoming Quarterly Report | View | |
8th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
14th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Know CareMax's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as CareMax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CareMax backward and forwards among themselves. CareMax's institutional investor refers to the entity that pools money to purchase CareMax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Tower Research Capital Llc | 2024-09-30 | 5.1 K | Bank Of America Corp | 2024-09-30 | 4 K | Barclays Plc | 2024-09-30 | 789 | Royal Bank Of Canada | 2024-09-30 | 500 | Fortitude Family Office Llc | 2024-09-30 | 187 | Bnp Paribas Arbitrage, Sa | 2024-09-30 | 182 | Cwm, Llc Duplicate | 2024-06-30 | 77.0 | Jpmorgan Chase & Co | 2024-09-30 | 54.0 | Citigroup Inc | 2024-09-30 | 34.0 | Deerfield Management Co | 2024-09-30 | 530.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 353.5 K |
Follow CareMax's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.91 M.Market Cap |
|
Project CareMax's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.87) | (1.78) | |
Return On Capital Employed | (3.56) | (3.38) | |
Return On Assets | (1.10) | (1.04) | |
Return On Equity | (11.12) | (10.57) |
When accessing CareMax's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CareMax's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CareMax's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in CareMax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CareMax. Check CareMax's Beneish M Score to see the likelihood of CareMax's management manipulating its earnings.
Evaluate CareMax's management efficiency
CareMax has return on total asset (ROA) of (0.1059) % which means that it has lost $0.1059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2842) %, meaning that it created substantial loss on money invested by shareholders. CareMax's management efficiency ratios could be used to measure how well CareMax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.78 in 2024. Return On Capital Employed is likely to rise to -3.38 in 2024. At this time, CareMax's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 26 M in 2024, despite the fact that Net Tangible Assets are likely to grow to (175 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 16.48 | 15.66 | |
Tangible Book Value Per Share | (52.75) | (55.38) | |
Enterprise Value Over EBITDA | (0.82) | (0.78) | |
Price Book Value Ratio | 0.91 | 0.86 | |
Enterprise Value Multiple | (0.82) | (0.78) | |
Price Fair Value | 0.91 | 0.86 | |
Enterprise Value | 433.9 M | 378.3 M |
Evaluating the management effectiveness of CareMax allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The CareMax Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 0.6337 | Revenue 784.6 M | Quarterly Revenue Growth (0.12) | Revenue Per Share 208.339 | Return On Equity (3.28) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CareMax insiders, such as employees or executives, is commonly permitted as long as it does not rely on CareMax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CareMax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CareMax time-series forecasting models is one of many CareMax's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CareMax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
CareMax Earnings per Share Projection vs Actual
CareMax Corporate Management
Carlos Solo | President, CoFounder | Profile | |
Samantha Swerdlin | Vice Relations | Profile | |
Niberto MD | Chief Officer | Profile | |
Nicole Cable | Chief Officer | Profile | |
Teresa McMeans | Chief Officer | Profile | |
Erick CPA | Chief Officer | Profile |
Additional Tools for CareMax Stock Analysis
When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.